Skip Navigation
< Back
Service Delivery Innovation Profile

Hospital-Based Program Protects Newborns by Providing Pertussis Vaccinations to Medically Underserved Hispanic Mothers and Caregivers


Tab for The Profile
Comments
(0)
   

Snapshot

Summary

The hospital-based Pertussis Cocooning Program provides pertussis booster vaccinations before hospital discharge to mothers who have just given birth, as part of standing orders; it also seeks to identify those who will be in regular contact with the newborn at home and educate them about their need to be immunized to protect the infant. The program, which caters to low-income, medically underserved and underinsured families, predominantly of Hispanic ethnicity, also runs a full-time clinic where these individuals can be vaccinated free of charge. The program has increased the use of pertussis vaccinations for mothers, family members, and others who will be in contact with infants born at the hospital.

Evidence Rating (What is this?)

Suggestive: The evidence consists of post-implementation data on pertussis vaccination rates for mothers and others who will be in regular contact with infants at home after discharge from the hospital.
begin doxml

Developing Organizations

Texas Children's Hospital
Houston, TXend do

Date First Implemented

2008
begin pp

Patient Population

Vulnerable Populations > Children; Race and Ethnicity > Hispanic/Latino-Latina; Age > Infant (1-23 months); Vulnerable Populations > Medically uninsured; Age > Newborn (0-1 month); Vulnerable Populations > Non-English speaking/Limited English proficiency; Racial minorities; Insurance Status > Uninsuredend pp

What They Did

Back to Top

Problem Addressed

Infants under 6 months of age (particularly Hispanic infants) face an increased risk of pertussis and pertussis-related deaths. These infants are too young to have received all three doses of the pertussis vaccine, and hence remain at risk of acquiring the infection, often from household contacts who have not been immunized.
  • Significant risk of pertussis in infants: In 2007, infants faced a 19 times higher risk of pertussis than did the typical American, with incidence rates of 69.99 cases per 100,000 infants (compared with 3.62 per 100,000 in the general population).1
  • Particularly among Hispanic infants: For unknown reasons, pertussis incidence and mortality are higher in infants of Hispanic ethnicity. In 2007, for example, Hispanic infants accounted for 70 percent of pertussis-related deaths.1
  • Unvaccinated household members as main source of infection: More than three-fourths of affected infants acquire the infection from an unvaccinated household contact, including 33 percent from their mother and 16 percent from their father.1
  • Unrealized potential of pertussis vaccination: A targeted vaccination strategy for pertussis has not been widely implemented, largely because of a lack of necessary infrastructure, a need for education, reimbursement issues, and logistical barriers.1

Description of the Innovative Activity

The hospital-based Pertussis Cocooning Program provides pertussis vaccinations before hospital discharge to mothers who have just given birth, as part of standing orders; it also seeks to identify those who will be in regular contact with the newborn at home and educate them about their need to be immunized to protect the infant. The program, which caters to low-income, medically underserved and underinsured families, predominantly of Hispanic ethnicity, also runs a full-time clinic where these individuals can receive the pertussis vaccine free of charge. The program was implemented in two phases: Phase 1 (January 2008 through May 2009) immunized mother only, phase 2 (June 2009 to date) expanded the service to also immunize contacts of newborn infants. Key program components include the following:
  • Raising awareness through educational materials: Program posters and print materials placed in antenatal and postnatal areas of the hospital inform mothers and family members about the need for all household members to be vaccinated against pertussis as protection for the newborn. Each mother also receives a family information packet, written in Spanish and English, that includes a description of the cocooning program, information about the hospital-based clinic for free vaccinations (see last bullet), a brochure about pertussis developed by the Texas Department of State Health Services, and a flyer listing community clinics where family members can receive free or low-cost vaccinations.
  • Identifying those in regular contact with infant: Nurses and other staff (with the aid of translators, when necessary) speak to mothers about the vaccine, including the need to vaccinate those who will interact regularly with the infant at home. They ask mothers to identify family members (e.g., siblings, grandparents, aunts, uncles) and other caregivers who will be in contact with the infant, and indicate their willingness to speak to them about being vaccinated if they come to the hospital. They also remind mothers about the hospital-based clinic that can provide free vaccinations to these individuals.
  • Vaccinating mother before discharge (per standing order): Per Centers for Disease Control and Prevention (CDC) guidelines, physicians working in obstetrics and maternity care add pertussis vaccination to the hospital’s preprinted standing orders for all women who have given birth. With informed consent, trained nurses vaccinate them before they leave the hospital (unless the vaccine is contraindicated for some reason).
  • Vaccinating others through free clinic: Two trained, bilingual nurses (one working full-time, one part-time) staff a clinic in the hospital, full time during the week and on weekends. The nurse reiterates the need for the vaccination to those who visit the clinic and provides the vaccination free of charge to family members and others who will be in regular contact with the newborn. Clinic nurses also distribute information about community programs that offer other free or low-cost vaccinations and services.

References/Related Articles

Guilford-Blake R. Insights on Protecting Infants Against Pertussis. Infectious Diseases, Pediatric News from the National Immunization Conference. October 2010.

Contact the Innovator

Mary Healy, MD
Assistant Professor in the Department of Pediatrics, Section of Infectious Diseases
Director of Vaccinology & Maternal Immunization at the Center for Vaccine Awareness and Research
Texas Children's Hospital
1102 Bates St., Suite 1120
Houston, TX 77030
Tel: (832) 824-1780
Fax: (832) 825-1048

Innovator Disclosures

Dr. Healy has not indicated whether she has financial interests or business/professional affiliations relevant to the work described in this profile.

Did It Work?

Back to Top

Results

The program has increased the use of pertussis vaccinations for mothers and other individuals who will be in regular contact with the newborns at home. The program's impact on pertussis incidence is currently being evaluated.
  • High vaccination rate for mothers: In Phase 1, 75 percent of women (8,334 of 11,174) who had given birth received tetanus, diphtheria, pertussis (Tdap) vaccine. During Phase 2 (June 2009 through December 31, 2010), 84 percent of women (6,157 of 7,312) were vaccinated; another 9 percent (673) had previously received Tdap vaccine, most from this program after the birth of a prior baby. (This increase was due, in large part, to the elimination of a requirement for a minimum 2-year interval since receipt of a tetanus-containing vaccine, before receiving the pertussis vaccine.) Before launching the program, the hospital did not routinely vaccinate these women. Current immunization rates exceed 93 percent.
  • High vaccination rate for others: During Phase 2, 4,323 family members and caregivers received vaccinations. Prior to implementation of this program, it is unlikely that these individuals knew they needed to be vaccinated.

Evidence Rating (What is this?)

Suggestive: The evidence consists of post-implementation data on pertussis vaccination rates for mothers and others who will be in regular contact with infants at home after discharge from the hospital.

How They Did It

Back to Top

Context of the Innovation

The Center for Vaccine Awareness and Research at Texas Children’s Hospital in Houston, Texas promotes vaccine delivery through research and education programs. The impetus for this program came from the aforementioned CDC recommendation to “cocoon” or protect infants from pertussis by immunizing caregivers. In response to this directive, Dr. Mary Healy and colleagues at the Center decided to develop a program in partnership with Ben Taub General Hospital, which serves a predominantly Hispanic population at high risk of pertussis. To their knowledge, theirs was the first attempt to create a hospital-based immunization program.

Planning and Development Process

Key steps included the following:

  • Designing program in two phases: In response to the CDC’s recommendation and the presence of a large, underserved Hispanic population at Ben Taub, Dr. Healy and her colleagues designed the two-phased program, with the first phase focused on vaccinating women who had given birth and the second focused on family members and other caregivers.
  • Obtaining program support and input from hospital staff: Based on the initial program design, Dr. Healy and her colleagues met with the chief of staff at Ben Taub to discuss the program’s feasibility and obtain support for it.
  • Developing implementation plan: The program team held numerous meetings with key individuals to develop a comprehensive implementation plan. Participants included the hospital’s chief of staff and director of medicine, along with department chairs and representatives from obstetrics, pediatrics, neonatal care, family practice, nursing, and pharmacy services.
  • Obtaining seed funding and donated vaccine: The program team submitted a successful proposal to the Baylor Methodist Community Health Fund, which awards grants for programs that provide heath care to underserved communities. Dr. Healy also contacted representatives of Sanofi Pasteur, the only manufacturer of pertussis vaccine at the time the program was implemented, who agreed to donate pertussis vaccine doses. The team worked with the head of the Ben Taub pharmacy to arrange for storage.
  • Educating staff: Program staff educated relevant hospital-based providers (including obstetricians, family practitioners, midwives, nursing personnel, and translators) during regular grand rounds and in small group sessions. During these sessions, staff learned about their role in the program, including how to explain its importance and benefits to mothers and family members.
  • Establishing clinic for other caregivers: The hospital allocated separate space for a clinic to provide vaccines to family members and other caregivers. The Center for Vaccine Awareness and Research hired bilingual nurses (fluent in both English and Spanish) to staff the clinic. (Ben Taub policy did not allow hospital staff to provide services to those who are not hospital patients.)

Resources Used and Skills Needed

  • Staffing: The program has a part-time director who spent 30 to 50 percent of her time on the program during the 18-month initial development and startup phase, and who now spends 20 to 25 percent of her time on program-related activities. The program also has a part-time research associate (30 percent); who consults on operating issues, maintains the program database, and evaluates outcomes; and an administrator (10 percent). Another faculty member from Baylor College of Medicine donates approximately 2 hours a week to support program-related research. Hospital staff provide program-related services to mothers as part of their regular duties. The hospital-based clinic serving family members and other caregivers is open 8 hours a day during the week and on weekends; it is staffed by one full-time and one part-time nurse.
  • Costs: Operating costs consist primarily of the salary and benefits for nurses who staff the clinic, which total roughly $111,000 a year. This cost excludes time spent by other individuals on the program (as outlined above) and vaccine-related costs (because to date the vaccine has been donated). At current market rates, each dose would cost $38.83 if purchased, before overhead and administrative costs are added.
begin fsxml

Funding Sources

Sanofi Pasteur; Baylor Methodist Community Health Fund; Children's Health Fund, Harris County Hospital District Foundation
The following organizations have provided funding for program startup and/or ongoing operations (e.g., to pay the salary of clinic nurses):

  • Baylor Methodist Community Health Fund ($100,000 in 2007, $75,000 in 2009, and $110,859 in 2011)
  • Children’s Health Fund of the Harris County Hospital District Foundation ($35,842)
  • Sanofi Pasteur (in-kind donations of vaccine and a research grant to track long-term outcomes related to pertussis incidence at the hospital).
end fs

Tools and Other Resources

For more information about the Center for Vaccine Awareness and Research, go to: http://www.texaschildrens.org/Locate/Departments-and-Services/Vaccine/.

For more information about the program, visit: http://www.vaccine.texaschildrens.org.

Adoption Considerations

Back to Top

Getting Started with This Innovation

  • Review hospital and state immunization policies: State laws and policies vary on who can provide vaccines and whether hospital staff can immunize nonpatients. Would-be adopters need to consider such laws and policies during the early stages of program design.
  • Identify champions to secure buy-in: The program cannot succeed without buy-in at all levels of the organization, including physician and hospital leaders and frontline provider staff. Program champions can help to win such support by touting the program's benefits to colleagues throughout the hospital.
  • Identify funding sources: Ongoing funding or in-kind donations will likely be needed to fund program operations, including the cost of vaccines and the nurses to staff the clinic.
  • Include translators in training: Hospital translators need to understand all aspects of the program, as they will be responsible for explaining it to patients and others with limited English proficiency.
  • Tailor educational materials to participant needs: Consider the reading level and educational background of the target audience when developing program-related educational materials. Materials should offer a straightforward reason for the program, outline the specific action to be taken (vaccination), and clearly explain how to take that action.
  • Maintain flexible clinic hours: At Ben Taub, most family and friends come late in the day (often after work or school) or on weekends to visit patients. Consequently, program developers established clinic hours that cater to these visiting patterns. Would-be adopters will need to analyze their own visiting patterns and schedule program services accordingly.

Sustaining This Innovation

  • Provide ongoing training: To address turnover and other internal staffing changes, provide inservice training about the program on a quarterly basis.
  • Stay abreast of new standards: Monitor CDC recommendations related to standards for pertussis immunizations and adapt the program to any changes.
  • Track pertussis infections among infants: Implement a system for tracking cases of pertussis infection among infants born to hospital and clinic patients. Such information will allow leaders to determine the program's impact on patient outcomes (rather than limiting evaluation to process measures, such as vaccination rates).

 
1 Healy CM, Rench MA, Baker CJ. Implementation of cocooning against pertussis in a high-risk population. Clin Infect Dis. 2011;52(2):157–162. [PubMed] Oxford University Press, 2011.
Comment on this Innovation

Disclaimer: The inclusion of an innovation in the Innovations Exchange does not constitute or imply an endorsement by the U.S. Department of Health and Human Services, the Agency for Healthcare Research and Quality, or Westat of the innovation or of the submitter or developer of the innovation. Read more.
Service Delivery Innovation Profile Classification

Disease/Clinical Category:
Stage of Care:
IOM Domains of Quality:
State:

Original publication: August 31, 2011.
Original publication indicates the date the profile was first posted to the Innovations Exchange.

Last updated: August 08, 2012.
Last updated indicates the date the most recent changes to the profile were posted to the Innovations Exchange.